Article
In Vivo Activity of Amodiaquine against Ebola Virus Infection
27 Dec 2019
Abstract excerpt
During the Ebola virus disease (EVD) epidemic in Western Africa (2013‒2016), antimalarial treatment was administered to EVD patients due to the high coexisting malaria burden in accordance with World Health Organization guidelines. In an Ebola treatment center in Liberia, EVD patients receiving the combination antimalarial artesunate-amodiaquine had a lower risk of death compared to those treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
